Restoring dendritic cell migration: a gut reaction to boost vaccine efficacy in aging.

Liwei Zhao, Oliver Kepp, Guido Kroemer, Peng Liu

Institut Gustave Roussy, Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, UMS AMMICa, Villejuif, France.Institut Gustave Roussy, Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, UMS AMMICa, Villejuif, France. · pubmed

Paper

Abstract

Aging impairs vaccine responses. Dai et al. reported that defective cDC2 migration in immunized old mice, diminishing humoral and cellular immunity. Oral yeast-derived nanoparticles restore DC migration and vaccine efficacy. These findings establish impaired DC migration as a key mechanism of age-related immune decline, introducing a noninvasive strategy to correct immunosenescence.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that restoring dendritic cell migration can enhance vaccine efficacy in aging individuals. This research addresses a key mechanism of immune decline associated with aging, aiming to improve immune responses rather than merely treating symptoms.

Author of this paper? Send a correction.